search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
6


ADVERTISEMENT FEATURE


COVER STORY: LIPOID KOSMETIK


Boosting astaxanthin benefits with phospholipids


Encapsulation of cosmetic active ingredients in skin-friendly particles potentiates their skin interaction and results in a superior and long- lasting cosmetic effect. PhytoSolve® Astaxanthin is an innovative natural product comprising a synergistic complex of the antioxidant astaxanthin (AXN) and natural phospholipids. AXN is produced by aquatic organisms


like Haematococcus pluvialis algae. It has a high capacity to scavenge reactive oxygen species (ROS) responsible for oxidative stress,1 contributing to skin ageing by damaging proteins, lipids and DNA within the cells. Topical AXN application has been reported to have several skin health benefits, including anti-wrinkle effects, protection against UV irradiation, and increased skin hydration, which suggest promising applications in anti-ageing products.


Phospholipids are highly versatile materials


offering both technical and physiological benefits for cosmetic formulations. They are endogenous, highly biocompatible, safe, and hence pre-destined for advanced skincare products.2 Owing to their amphiphilic nature and


their ability to interact with human skin, phospholipids can serve as active ingredients for skin protection and skin rejuvenation, as carrier systems for cosmetic active ingredients, and as skin-friendly emulsifiers. PhytoSolve® Astaxanthin is a complex


between AXN and highly purified soybean phospholipids (non-GMO). The small oil droplet size (ca. 50-100 nm diameter) of the emulsion and the solubilisation of AXN in the oil droplets enable a strong interaction with the skin to synergistically enhance the cosmetic benefits (Figure 1).


Technical product features PhytoSolve® Astaxanthin is a deep red liquid concentrate containing 4 mg/mL of natural AXN from Haematococcus pluvialis encapsulated in a pre-formulated emulsion. The product is vegan, free of preservatives, and comprises raw materials from non-GMO origin without palm/ palm kernel oil or its derivatives. PhytoSolve® Astaxanthin can be added easily to aqueous and semi-solid formulations during the cooling phase within a recommended pH range of 5 to 8. Resulting formulations take on a pleasant, pastel peach to vivid orange-red colour that gives the skin a healthy and glowing appearance (Figure 2).


Studies on the cosmetic effects of PhytoSolve® Astaxanthin Enhancement of skin antioxidant potential


PERSONAL CARE June 2024


Interview: Clariant global personal care VP Michael Haspel


In focus: Skin care Naturals Sun care


Plus: Harnessing the power of microbiome manipulation


The antioxidant properties of PhytoSolve® Astaxanthin in comparison to a placebo formulation were evaluated in vitro by measurement of the skin antioxidant potential (SAP). The SAP was determined by labelling a skin sample with a test radical and quantifying the decrease in free radical concentration 10 and 30 minutes after application of the test formulations.3 The SAP value of the placebo cream was


normalized to 100%. The cream with 10% PhytoSolve® Astaxanthin showed an increase of the SAP value to 125% (after ten minutes) and 148% (after 30 minutes) (Figure 3). The study confirmed a significantly higher SAP for PhytoSolve® Astaxanthin than for the


Phospholipids Hydrophilic Head June 2024 PERSONAL CARE INGREDIENTS ● FORMULATION ●


MANUFACTURE GLOBAL


placebo formulation. Therefore, the antioxidant activity of PhytoSolve® Astaxanthin in the skin was successfully demonstrated.


Protection from skin damage caused by UVB irradiation In a further in vitro study the protective effect of PhytoSolve® Astaxanthin against UVB irradiation, which is an important environmental driver of skin ageing, was assessed. The viability of a cell-based full- thickness skin model was measured with an established dye-based assay4


after the


following treatments: (1) no irradiation, (2) UBV-irradiation with 80 mJ/cm2 irradiation with 80 mJ/cm2


the test formulation. The non-irradiated sample functioned


as control and showed full viability. After irradiation, the viability decreased to 63%. When applying the formulation containing 10% PhytoSolve® Astaxanthin, the adverse effects of UVB-irradiation have been eliminated and a cell viability of 98% was maintained (data not shown). Therefore, PhytoSolve® Astaxanthin


effectively protects the skin from UVB irradiation-caused damage and maintains skin viability.


Clinical study on anti-ageing effects and consumer satisfaction In order to examine the efficacy and tolerability of PhytoSolve® Astaxanthin, the product was tested by 20 male and female volunteers with healthy skin under the supervision of a dermatologist. The volunteers applied a cream containing 2% PhytoSolve® Astaxanthin twice daily for 28 days.


Emulsion Solubilized AXN , and (3) UBV- after application of


Lipophilic Tail


Figure 1: Schematic picture of phospholipids and their role as emulsifiers in the formation of oil droplets, in which AXN is dissolved


www.personalcaremagazine.com


Title page © Shutterstock, Stock Photo ID: 249715174, creator: ifong


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80